647 related articles for article (PubMed ID: 19205968)
1. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
Conran N; Franco-Penteado CF; Costa FF
Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte adhesion in sickle cell disease.
Parise LV; Telen MJ
Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
[TBL] [Abstract][Full Text] [Related]
3. Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion.
Montes RA; Eckman JR; Hsu LL; Wick TM
Am J Hematol; 2002 Jul; 70(3):216-27. PubMed ID: 12111767
[TBL] [Abstract][Full Text] [Related]
4. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
5. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
Akinsheye I; Klings ES
J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell disease at the dawn of the molecular era.
Abboud MR; Musallam KM
Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell vaso-occlusion.
Fabry ME; Kaul DK
Hematol Oncol Clin North Am; 1991 Jun; 5(3):375-98. PubMed ID: 1864816
[TBL] [Abstract][Full Text] [Related]
9. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
Hebbel RP; Osarogiagbon R; Kaul D
Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
Stuart MJ; Setty BN
Pediatr Pathol Mol Med; 2001; 20(1):27-46. PubMed ID: 12673843
[TBL] [Abstract][Full Text] [Related]
11. Investigational drugs in sickle cell anemia.
Kotiah SD; Ballas SK
Expert Opin Investig Drugs; 2009 Dec; 18(12):1817-28. PubMed ID: 19780709
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of sickle cell disease.
Beuzard Y
Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology of sickle cell disease].
Elion J; Laurance S; Lapouméroulie C
Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion in sickle cell disease.
Marouf R
Hemoglobin; 2011; 35(5-6):495-502. PubMed ID: 21981466
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Wood KC; Granger DN
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and treatment of sickle cell disease.
Raphael RI
Clin Adv Hematol Oncol; 2005 Jun; 3(6):492-505. PubMed ID: 16167028
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiologically based drug treatment of sickle cell disease.
Steinberg MH
Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
[TBL] [Abstract][Full Text] [Related]
19. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
Connes P; Machado R; Hue O; Reid H
Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies.
Okoli K; Irani F; Horvath W
Med Hypotheses; 2009 May; 72(5):578-80. PubMed ID: 19138828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
